Login
Register
Home
CME/CE
Oncology
Supplements
Resources
Links
Video Library
About Us
Contact Us
Services
FAQs
Policies
Authored Items
Considerations in Non-Hodgkin's Lymphoma: Clinical Trial Updates
André Goy, MD, MS
,
Amanda Copeland, MSN, RN, CNS
,
Anas Younes, MD
,
Sandra E. Kurtin, RN, MS, AOCN, ANP-C
,
Nelly G. Adel, PharmD, BCOP, BCPS
Supplements
Considerations in Non-Hodgkin's Lymphoma: T-Cell Lymphomas
Andrei Shustov, MD
,
Nora M. Mueller, PharmD
,
André Goy, MD, MS
Supplements
Considerations in Non-Hodgkin's Lymphoma: Diffuse Large B-Cell Lymphoma
André Goy, MD, MS
,
Betty M. Chan, PharmD, BCOP
,
Christine Liebertz, RN, CS, MSN, AOCN
Supplements
Considerations in Non-Hodgkin's Lymphoma: Waldenstrom's Macroglobulinemia
André Goy, MD, MS
,
Amy Goodrich, RN, MSN, CRNP
,
Zaven R. Norigian, PharmD, BCOP
Supplements
Considerations in Non-Hodgkin's Lymphoma: Follicular Lymphoma
André Goy, MD, MS
,
Andrew M. Evens, DO, MSc
,
Sonja Crandon, RN, BSN
,
Cindy L. O'Bryant, PharmD, BCOP
Supplements
Considerations in Non-Hodgkin's Lymphoma: Mantle Cell Lymphoma
André Goy, MD, MS
,
Steven H. Bernstein, MD
Supplements
Last modified: November 17, 2010
Login
Register
Home
CME/CE
Oncology
Supplements
Resources
Links
Video Library
About Us
Contact Us
Services
FAQs
Policies